Crain s Content Studio: Empire Anthem | Crain s New York Business
The Covid-19 pandemic has brought extraordinary challenges to all New Yorkers. Families have grappled with the devastating impact of the virus, and businesses and workers have faced financial distress. In many respects, the crisis has brought out the best in New Yorkers as they step up to make a difference whether in a hospital intensive care unit serving patients, in a restaurant kitchen making meals for front-line workers and the elderly, or in a research laboratory seeking vaccines and treatments to battle Covid-19.
Today, Empire BlueCross BlueShield is honored to recognize 50 Whole Health Heroes who unflinchingly have fought against the unseen enemy, often sacrificing their own health and personal comfort to help others. These New Yorkers, who hail from the health care sector, the business world and the nonprofit field, have displayed extraordinary leadership, dedication, empathy, and remarkable compassion to he
EGFR Resisters and LUNGevity Foundation Partner on Lung Cancer Research Award prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Share this article
OSLO, Feb. 18, 2021 /PRNewswire/
Targovax ASA, a clinical stage immuno-oncology company developing immune activators to target hard-to-treat solid tumors, will host a virtual Capital Markets Day for investors, analysts and journalists today at 2:30 PM CET. The Capital Markets Day will feature presentations from executive management and Alexander Shousthari, Clinical Director Melanoma Services at Memorial Sloan Kettering Cancer Center, and will be webcast live and accessible at https://www.targovax.com/en/capital-markets-day-2021/
Based on the strong clinical data that are now generated on ONCOS-102, Targovax has a solid fundament to move into late stage clinical development. We also have a broader pipeline of preclinical assets that could create a broader horizon of opportunities in the future. The Capital Markets day will feature presentations updating the market on these aspects.
Weizmann Institute of Science
The findings might help identify those at extra risk of this cancer and develop means of prevention
Inflammation promotes some of the deadliest cancers. In the colon, inflammatory bowel disease is well known to be associated with higher-than-average rates of malignancy. Nevertheless, the developing tumor is commonly diagnosed only when it has already advanced or even metastasized, possibly because the early symptoms of malignancy are often mistakenly ascribed to a flare-up of intestinal inflammation. Weizmann Institute of Science researchers have now revealed a molecular missing link between chronic gut inflammation and cancer. This revelation may help develop ways of preventing colon cancers in people with inflammatory diseases of the intestines.
(YMAB), United Therapeutics Corporation (NASDAQ:UTHR) - Y-mAbs Therapeutics Raises $100M Via Equity To Fund Commercial Rollout Of Neuroblastoma Med benzinga.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from benzinga.com Daily Mail and Mail on Sunday newspapers.